Works matching IS 00071188 AND DT 2021 AND VI 178 AND IP 2

Results: 11

Developing cell therapies as drug products.
Published in:
British Journal of Pharmacology, 2021, v. 178, n. 2, p. 262, doi. 10.1111/bph.15305
By:
- Ciccocioppo, Rachele;
- Comoli, Patrizia;
- Astori, Giuseppe;
- Bufalo, Francesca;
- Prapa, Malvina;
- Dominici, Massimo;
- Locatelli, Franco
Publication type:
Article
Selected Abstracts From Pharmacology 2020.
Published in:
British Journal of Pharmacology, 2021, v. 178, n. 2, p. 381, doi. 10.1111/bph.15316
Publication type:
Article
A novel class of fast-acting antimalarial agents: Substituted 15-membered azalides.
Published in:
2021
By:
- Peric, Mihaela;
- Pešić, Dijana;
- Alihodžić, Sulejman;
- Fajdetić, Andrea;
- Herreros, Esperanza;
- Gamo, Francisco Javier;
- Angulo‐Barturen, Iñigo;
- Jiménez‐Díaz, María Belén;
- Ferrer‐Bazaga, Santiago;
- Martínez, María S.;
- Gargallo‐Viola, Domingo;
- Mathis, Amanda;
- Kessler, Albane;
- Banjanac, Mihailo;
- Padovan, Jasna;
- Bencetić Mihaljević, Vlatka;
- Munic Kos, Vesna;
- Bukvić, Mirjana;
- Eraković Haber, Vesna;
- Spaventi, Radan
Publication type:
journal article
Mechanisms of enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategies to overcome it.
Published in:
2021
By:
- Wang, Yuanyuan;
- Chen, Jiyuan;
- Wu, Zhengjie;
- Ding, Weihong;
- Gao, Shen;
- Gao, Yuan;
- Xu, Chuanliang
Publication type:
journal article
Small intestinal glucose and sodium absorption through calcium‐induced calcium release and store‐operated Ca2+ entry mechanisms.
Published in:
British Journal of Pharmacology, 2021, v. 178, n. 2, p. 346, doi. 10.1111/bph.15287
By:
- Zhang, Fenglian;
- Wan, Hanxing;
- Chu, Fenglan;
- Lu, Cheng;
- Chen, Jun;
- Dong, Hui
Publication type:
Article
Targeted inhibition of Rev‐erb‐α/β limits ferroptosis to ameliorate folic acid‐induced acute kidney injury.
Published in:
British Journal of Pharmacology, 2021, v. 178, n. 2, p. 328, doi. 10.1111/bph.15283
By:
- Guo, Lianxia;
- Zhang, Tianpeng;
- Wang, Fei;
- Chen, Xun;
- Xu, Haiman;
- Zhou, Cui;
- Chen, Min;
- Yu, Fangjun;
- Wang, Shuai;
- Yang, Deguang;
- Wu, Baojian
Publication type:
Article
Bleomycin: A novel osteogenesis inhibitor of dental follicle cells via a TGF-β1/SMAD7/RUNX2 pathway.
Published in:
2021
By:
- Li, Zhi‐Zheng;
- Wang, Hai‐Tao;
- Lee, Grace Y.;
- Yang, Ying;
- Zou, Yan‐Ping;
- Wang, Bing;
- Gong, Chu‐Jie;
- Cai, Yu;
- Ren, Jian‐Gang;
- Zhao, Ji‐Hong;
- Li, Zhi-Zheng;
- Wang, Hai-Tao;
- Zou, Yan-Ping;
- Gong, Chu-Jie;
- Ren, Jian-Gang;
- Zhao, Ji-Hong
Publication type:
journal article
Commentary on "Re‐regulation of hepatic stellate cell contraction and cirrhotic portal hypertension by Wnt/β‐catenin signaling via interaction with Gli1".
Published in:
British Journal of Pharmacology, 2021, v. 178, n. 2, p. 378, doi. 10.1111/bph.15282
By:
- Weiskirchen, Ralf
Publication type:
Article
NH‐sulfoximine: A novel pharmacological inhibitor of the mitochondrial F1Fo‐ATPase, which suppresses viability of cancerous cells.
Published in:
British Journal of Pharmacology, 2021, v. 178, n. 2, p. 298, doi. 10.1111/bph.15279
By:
- Strobbe, Daniela;
- Pecorari, Rosalba;
- Conte, Oriana;
- Minutolo, Antonella;
- Hendriks, Christine M. M.;
- Wiezorek, Stefan;
- Faccenda, Danilo;
- Abeti, Rosella;
- Montesano, Carla;
- Bolm, Carsten;
- Campanella, Michelangelo
Publication type:
Article
Identification and characterization of a novel adiponectin receptor agonist adipo anti‐inflammation agonist and its anti‐inflammatory effects in vitro and in vivo.
Published in:
British Journal of Pharmacology, 2021, v. 178, n. 2, p. 280, doi. 10.1111/bph.15277
By:
- Qiu, Wei;
- Wu, Hongle;
- Hu, Zhekai;
- Wu, Xingwen;
- Tu, Maxwell;
- Fang, Fuchun;
- Zhu, Xiaofang;
- Liu, Yao;
- Lian, Junxiang;
- Valverde, Paloma;
- Van Dyke, Thomas;
- Steffensen, Bjorn;
- Dong, Lily Q.;
- Tu, Qisheng;
- Zhou, Xuedong;
- Chen, Jake
Publication type:
Article
Issue Information.
Published in:
British Journal of Pharmacology, 2021, v. 178, n. 2, p. 237, doi. 10.1111/bph.15107
Publication type:
Article

Works matching IS 00071188 AND DT 2021 AND VI 178 AND IP 2

Developing cell therapies as drug products.

Selected Abstracts From Pharmacology 2020.

A novel class of fast-acting antimalarial agents: Substituted 15-membered azalides.

Mechanisms of enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategies to overcome it.

Small intestinal glucose and sodium absorption through calcium‐induced calcium release and store‐operated Ca<sup>2+</sup> entry mechanisms.

Targeted inhibition of Rev‐erb‐α/β limits ferroptosis to ameliorate folic acid‐induced acute kidney injury.

Bleomycin: A novel osteogenesis inhibitor of dental follicle cells via a TGF-β1/SMAD7/RUNX2 pathway.

Commentary on "Re‐regulation of hepatic stellate cell contraction and cirrhotic portal hypertension by Wnt/β‐catenin signaling via interaction with Gli1".

NH‐sulfoximine: A novel pharmacological inhibitor of the mitochondrial F<sub>1</sub>F<sub>o</sub>‐ATPase, which suppresses viability of cancerous cells.

Identification and characterization of a novel adiponectin receptor agonist adipo anti‐inflammation agonist and its anti‐inflammatory effects in vitro and in vivo.

Issue Information.